
China’s NMPA Approves IND for SKB107 for Solid Tumor Bone Metastases
China’s Center for Drug Evaluation of the National Medical Products Administration has approved the investigational new drug application for the radionucleotide-drug conjugate (RDC) SKB107 (formerly TBM-001) for the management of bone metastases in …